The store will not work correctly when cookies are disabled.
1-(4-fluorophenyl)-4-(4-(pyrimidin-2-yl)-1,4-diazepan-1-yl)butan-1-one oxime
ID: ALA4554850
PubChem CID: 155556295
Max Phase: Preclinical
Molecular Formula: C19H24FN5O
Molecular Weight: 357.43
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: O/N=C(/CCCN1CCCN(c2ncccn2)CC1)c1ccc(F)cc1
Standard InChI: InChI=1S/C19H24FN5O/c20-17-7-5-16(6-8-17)18(23-26)4-1-11-24-12-3-13-25(15-14-24)19-21-9-2-10-22-19/h2,5-10,26H,1,3-4,11-15H2/b23-18-
Standard InChI Key: NBTOXXDFQOHTRO-NKFKGCMQSA-N
Molfile:
RDKit 2D
26 28 0 0 0 0 0 0 0 0999 V2000
24.0356 -2.8436 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.0344 -3.6632 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.7425 -4.0721 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.4521 -3.6627 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.4493 -2.8400 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.7407 -2.4348 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.3264 -4.0712 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
26.1555 -2.4288 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.8647 -2.8347 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.1524 -1.6116 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
25.4431 -1.2057 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
27.5709 -2.4234 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.2801 -2.8294 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.9863 -2.4181 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
28.9255 -1.6104 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.5226 -1.0497 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.6674 -2.8794 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.3305 -1.1635 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.4481 -2.6334 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.7403 -1.8692 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
31.5568 -1.8655 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.9664 -2.5731 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
32.7821 -2.5697 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.1880 -1.8602 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.7721 -1.1527 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.9578 -1.1595 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
2 7 1 0
5 8 1 0
8 9 1 0
8 10 2 0
10 11 1 0
9 12 1 0
12 13 1 0
13 14 1 0
14 15 1 0
15 16 1 0
14 17 1 0
16 18 1 0
17 19 1 0
18 20 1 0
19 20 1 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 25 1 0
25 26 2 0
26 21 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 357.43 | Molecular Weight (Monoisotopic): 357.1965 | AlogP: 2.79 | #Rotatable Bonds: 6 |
Polar Surface Area: 64.85 | Molecular Species: BASE | HBA: 6 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 7.15 | CX Basic pKa: 8.91 | CX LogP: 1.35 | CX LogD: 1.24 |
Aromatic Rings: 2 | Heavy Atoms: 26 | QED Weighted: 0.49 | Np Likeness Score: -1.87 |
References
1. Al-Ghanim L, Zhu XY, Asong G, Ablordeppey SY.. (2019) SYA 013 analogs as moderately selective sigma-2 (σ2) ligands: Structure-affinity relationship studies., 27 (12): [PMID:30737135] [10.1016/j.bmc.2019.01.035] |